Hpb SCIE

国际简称：HPB 参考译名：血红蛋白

主要研究方向：GASTROENTEROLOGY & HEPATOLOGY-SURGERY 非预警期刊审稿周期：约1月

《血红蛋白》(Hpb)是一本由John Wiley and Sons Inc.出版的以GASTROENTEROLOGY & HEPATOLOGY-SURGERY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q1 JCR分区
172 年发文量
2.7 IF影响因子
未开放 是否OA
62 H-index
1998 创刊年份
12 issues/year 出版周期
English 出版语言

HPB is an international forum for clinical, scientific and educational communication.

Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.

Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.

HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.

Abstracted and Indexed in:

MEDLINE®

EMBASE

PubMed

Science Citation Index Expanded

Academic Search (EBSCO)

HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).

[ 查看全部 ]

投稿咨询加急咨询

Hpb期刊信息

ISSN：1365-182X
出版语言：English
是否OA：未开放
E-ISSN：1477-2574
出版地区：ENGLAND
是否预警：否
出版商：John Wiley and Sons Inc.
出版周期：12 issues/year
创刊时间：1998
开源占比：0.1
Gold OA文章占比：75.97%
OA被引用占比：0.0421...
出版国人文章占比：0.08
出版撤稿占比：0
研究类文章占比：87.21%

Hpb CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

5.6

1.141

1.15

学科类别	分区	排名	百分位
大类：Medicine 小类：Gastroenterology	Q2	44 / 167	73%
大类：Medicine 小类：Hepatology	Q2	30 / 82	64%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Hpb中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	SURGERY 外科 GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	3区 4区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学 SURGERY 外科	3区 3区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学 SURGERY 外科	3区 3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学 SURGERY 外科	4区 3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学 SURGERY 外科	3区 3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	SURGERY 外科 GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	2区 3区

Hpb JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	64 / 143	55.6%
学科：SURGERY	SCIE	Q1	56 / 290	80.9%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q1	34 / 143	76.57%
学科：SURGERY	SCIE	Q2	74 / 290	74.66%

Hpb历年数据统计

影响因子

中科院分区

Hpb中国学者发文选摘

1、Preoperative prediction model of microvascular invasion in patients with hepatocellular carcinoma
Author: Zhang, Jianfeng; Zeng, Fanxin; Jiang, Shijie; Tang, Hui; Zhang, Jian

Journal: HPB. 2023; Vol. 25, Issue 1, pp. 45-53. DOI: 10.1016/j.hpb.2022.08.007
2、Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China
Author: Yang, Shun-Chao; Liang, Lei; Wang, Ming-Da; Wang, Xian -Ming; Gu, Li -Hui; Lin, Kong-Ying; Zhou, Ya-Hao; Chen, Ting-Hao; Gu, Wei-Min; Li, Jie; Wang, Hong; Chen, Zhong; Li, Chao; Yao, Lan-Qing; Diao, Yong-Kang; Sun, Li -Yang; Zhang, Cheng-Wu; Zeng, Yong-Yi; Lau, Wan Yee; Huang, Dong-Sheng; Shen, Feng; Yang, Tian

Journal: HPB. 2023; Vol. 25, Issue 1, pp. 81-90. DOI: 10.1016/j.hpb.2022.09.002
3、Beyond successful hemostasis: CT findings and organ failure predict postoperative death in patients suffering from post-pancreatoduodenectomy hemorrhage
Author: Yang, Jie; Chen, Yonghua; Liu, Xubao; Zheng, Zhenjiang; Wang, Xing; Li, Yichen; Tan, Chunlu

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 252-259. DOI: 10.1016/j.hpb.2022.11.004
4、Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma
Author: Lima, Henrique A.; Alaimo, Laura; Brown, Zachary J.; Endo, Yutaka; Moazzam, Zorays; Tsilimigras, Diamantis I.; Shaikh, Chanza; Resende, Vivian; Guglielmi, Alfredo; Ratti, Francesca; Aldrighetti, Luca; Marques, Hugo P.; Soubrane, Olivier; Lam, Vincent; Poultsides, George A.; Popescu, Irinel; Alexandrescu, Sorin; Martel, Guillaume; Hugh, Tom; Endo, Itaru; Shen, Feng; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 260-268. DOI: 10.1016/j.hpb.2022.11.008
5、Analysis of conditional survival in primary hepatocellular carcinoma after narrow-margin hepatectomy: a large- sample, dual-centre, retrospective study
Author: Kong, Jie; Huang, Tingfeng; Zhang, Jianxi; Tang, Shichuan; Liu, Hongzhi; Liu, Jingfeng; Zeng, Yongyi

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 179-188. DOI: 10.1016/j.hpb.2022.08.005
6、Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy
Author: Endo, Yutaka; Moazzam, Zorays; Alaimo, Laura; Lima, Henrique A.; Munir, Muhammad M.; Shaikh, Chanza F.; Guglielmi, Alfredo; Aldrighetti, Luca; Weiss, Matthew; Bauer, Todd W.; Alexandrescu, Sorin; Poultsides, George A.; Kitago, Minoru; Maithel, Shishir K.; Marques, Hugo P.; Martel, Guillaume; Pulitano, Carlo; Shen, Feng; Cauchy, Francois; Koerkamp, Bas G.; Endo, Itaru; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 229-238. DOI: 10.1016/j.hpb.2022.10.011
7、Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma
Author: Endo, Yutaka; Lima, Henrique A.; Alaimo, Laura; Moazzam, Zorays; Brown, Zachary; Shaikh, Chanza F.; Ratti, Francesca; Marques, Hugo P.; Soubrane, Olivier; Lam, Vincent; Poultsides, George A.; Popescu, Irinel; Alexandrescu, Sorin; Martel, Guillaume; Workneh, Aklile; Guglielmi, Alfredo; Hugh, Tom; Aldrighetti, Luca; Shen, Feng; Endo, Itaru; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 3, pp. 353-362. DOI: 10.1016/j.hpb.2022.12.009
8、Efficiency of percutaneous transhepatic cholangioscopy in the treatment of biliary complications after liver transplantation
Author: Yasen, Aimaiti; Feng, Jun; Liang, Run-Bin; Zhu, Can-Hua; Li, Jun; Liu, An-Zhong; Liu, Yan-Min; Wang, Guo-Ying

Journal: HPB. 2023; Vol. 25, Issue 4, pp. 463-471. DOI: 10.1016/j.hpb.2023.01.010